Search Results - "Phyo, Aung Pyae"

Altered Pharmacokinetics and Delayed Sputum Conversion in Tuberculosis Patients Co‐Infected With HIV.

Authors: Phyo, Aung Pyae Hoglund, Richard M. Saito, Makoto et al.

Source: Tropical Medicine & International Health. May2026, p1. 12p. 2 Illustrations.

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Authors: Thu, Aung Myint Phyo, Aung Pyae Pateekhum, Chanapat et al.

Source: Malaria Journal. 5/8/2024, Vol. 23 Issue 1, p1-11. 11p.

A systematic review of neglected tropical diseases (NTDs) in Myanmar.

Authors: Swe, Myo Maung Maung Phyo, Aung Pyae Cooper, Ben S. et al.

Source: PLoS Neglected Tropical Diseases. 11/1/2023, Vol. 17 Issue 11, p1-17. 17p.

Severe falciparum malaria in pregnancy in Southeast Asia: a multi-centre retrospective cohort study.

Authors: Saito, Makoto Phyo, Aung Pyae Chu, Cindy et al.

Source: BMC Medicine. 8/24/2023, Vol. 21 Issue 1, p1-14. 14p.

Clinical impact of vivax malaria: A collection review.

Authors: Phyo, Aung Pyae Dahal, Prabin Mayxay, Mayfong et al.

Source: PLoS Medicine. 1/18/2022, Vol. 19 Issue 1, p1-23. 23p. 4 Charts, 1 Graph, 1 Map.

How can the ethical conduct of verbal autopsies be enhanced? Lessons from Southeast Asia.

Authors: Htun, Nan Shwe Nwe Adhikari, Bipin Phyo, Aung Pyae et al.

Source: Global Bioethics. Dec2025, Vol. 36 Issue 1, p1-9. 9p.

Investigating the Abbott-Bioline™ malaria antigen Pf/Pv rapid diagnostic test.

Authors: Aung, May Thu Thu Thu, Aung Myint Phyo, Aung Pyae et al.

Source: Malaria Journal. 10/15/2025, Vol. 24 Issue 1, p1-14. 14p.

Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border.

Authors: Phyo, Aung Pyae Win, Kyaw Kyaw Thu, Aung Myint et al.

Source: Malaria Journal. 1/15/2018, Vol. 17, p1-N.PAG. 5p. 2 Graphs.

Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.

Authors: Bonnington, Craig A. Phyo, Aung Pyae Ashley, Elizabeth A. et al.

Source: Malaria Journal. 11/25/2017, Vol. 16, p1-7. 7p. 1 Diagram, 1 Chart, 2 Graphs, 1 Map.

Combating multidrug-resistant Plasmodium falciparum malaria.

Authors: Thu, Aung Myint Phyo, Aung Pyae Landier, Jordi et al.

Source: FEBS Journal. Aug2017, Vol. 284 Issue 16, p2569-2578. 10p.

Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis..

Authors: Ko Aung, Htet Ko Swe, Lei Lei Saito, Makoto et al.

Source: Wellcome Open Research. 2023, p1-27. 27p.

Subject Terms: *Disease outbreaks, COVID-19, Tuberculosis treatment, Disease progression, Disease remission

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate- Mefloquine for Falciparum Malaria in Asia.

Authors: Valecha, Neena Phyo, Aung Pyae Mayxay, Mayfong et al.

Source: PLoS ONE. 2010, Vol. 5 Issue 7, p1-13. 13p. 1 Diagram, 7 Charts, 1 Graph.

Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.

Authors: Ashley, Elizabeth A Phyo, Aung Pyae Carrara, Verena I et al.

Source: Journal of Infectious Diseases. Jul2019, Vol. 220 Issue 1, p100-104. 5p.

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Authors: Chu, Cindy S Phyo, Aung Pyae Turner, Claudia et al.

Source: Clinical Infectious Diseases. 4/15/2019, Vol. 68 Issue 8, p1311-1319. 9p.

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.

Authors: Chu, Cindy S Phyo, Aung Pyae Lwin, Khin Maung et al.

Source: Clinical Infectious Diseases. 11/15/2018, Vol. 67 Issue 10, p1543-1549. 7p.

This result is not displayed to guests.
Login for full access.

Plasmodium vivax Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand.

Authors: Chu, Cindy S Lwin, Khin Maung Burgoine, Kathy et al.

Source: Open Forum Infectious Diseases. Jan2026, Vol. 13 Issue 1, p1-8. 8p.

Drugs in Development for Malaria.

Authors: Ashley, Elizabeth A. Phyo, Aung Pyae

Source: Drugs. Jun2018, Vol. 78 Issue 9, p861-879. 19p.

Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?

Authors: Ashley, Elizabeth A Phyo, Aung Pyae

Source: Lancet Infectious Diseases. Aug2020, Vol. 20 Issue 8, p883-885. 3p.

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Authors: Phyo, Aung Pyae Jittamala, Podjanee Nosten, François H et al.

Source: Lancet Infectious Diseases. Jan2016, Vol. 16 Issue 1, p61-69. 9p.